Ellen Fercho

Q: What is Ellen Fercho email address?

Email Ellen Fercho at emofercho@aol.com and ellen.fercho@boehringer-ingelheim.com. This email is the most updated Ellen Fercho's email found in 2026.

Q: How to contact Ellen Fercho?

To contact Ellen Fercho send an email to emofercho@aol.com or ellen.fercho@boehringer-ingelheim.com. (updated on August 25, 2024)

Senior Interstitial Lung Disease Consultant at Boehringer Ingelheim | St Louis, Missouri, United States

About Ellen Fercho

Ellen Fercho is a distinguished Senior Interstitial Lung Disease Consultant at Boehringer Ingelheim, where she leverages her extensive expertise in specialty pharmaceutical sales to make a significant impact in the field of rare lung diseases. With a proven track record of success, Ellen is dedicated to promoting innovative orphan drugs that address unmet medical needs for patients suffering from interstitial lung disease (ILD). Her role encompasses a comprehensive approach to sales, where she is deeply involved in the entire process—from product promotion to navigating access and reimbursement challenges, as well as ensuring patient education and adherence.

Ellen's ability to adapt to the dynamic landscape of the pharmaceutical industry has been a cornerstone of her success. She has consistently achieved outstanding sales performance, exemplified by her remarkable accomplishment of finishing 145% to quota in 2016, ranking first in her region and sixth nationally. This achievement underscores her strategic approach to hospital sales and her adeptness in managing complex sales operations within the highly competitive biotechnology sector.

Her expertise extends beyond sales metrics; Ellen is passionate about educating healthcare professionals and patients alike about the nuances of ILD and the importance of effective pain management. Her skills in product launch and her deep understanding of pulmonology and gastroenterology enable her to build strong relationships with key stakeholders, ensuring that patients receive the best possible care. As she continues to drive success at Boehringer Ingelheim, Ellen remains committed to advancing the treatment landscape for rare lung diseases, making a lasting difference in the lives of patients and their families.

Ellen Fercho Work